Autori: Vogl FD
Naslov | Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22 (Meeting Abstract) |
Autori | Siefker-Radtke Arlene O Lugowska Iwona Tupikowski Krzysztof Andric Zoran G Rezazadeh-Kalebasty A Curigliano Giuseppe Vaena Daniel A Vogl FD Currie Graeme Abella S Kelly William Kevin |
Info | ANNALS OF ONCOLOGY, (2019), vol. 30 br. , Suppl. 5, str. 365-365 |
Projekat | Rainier Therapeutics, Inc. |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|